STOCK TITAN

PetVivo CEO buys 31,250 shares at $0.80

PetVivo’s CEO John Lai acquired restricted shares and a warrant through a private placement investment, increasing his direct equity position.

(Neutral)
(Neutral)
Form Type
4/A

Rhea-AI Filing Summary

PetVivo Holdings, Inc. (PETV) reports that Chief Executive Officer and director John Lai acquired 31,250 shares of restricted common stock on September 9, 2026 at $0.80 per share in connection with a private placement investment. Following this award, he directly holds 2,413,163 common shares.

On September 8, 2026 he also acquired a Common Stock Warrant covering 31,250 shares, with an exercise price of $1.10 per share and an expiration date of September 9, 2029. No Rule 10b5-1 trading plan is reported for these acquisitions.

Positive

  • None.

Negative

  • None.
Insider Lai John
Role Chief Executive Officer
Type Security Shares Price Value
Grant/Award Common Stock F1 31,250 $0.80 $25K
Conversion Common Stock Warrant 31,250 $0.00 $0.00
Holdings After Transaction: Common Stock Warrant — 31,250 contracts (Direct); Common Stock — 2,413,163 shares (Direct)
Footnotes (1)
  1. F1. Represents the acquisition of restricted common stock and warrants by the Reporting Person in connection with a private plaement investment in the Company pursuant to a subscription agreement.
Restricted common shares acquired 31,250 shares Award to John Lai on September 9, 2026 in a private placement investment
Acquisition price per restricted share $0.80 per share Restricted common stock acquired by John Lai on September 9, 2026
Common shares held after transaction 2,413,163 shares Direct common stock ownership of John Lai after the reported award
Warrant shares 31,250 shares Common Stock Warrant acquired by John Lai on September 8, 2026
Warrant exercise price $1.10 per share Exercise price of the Common Stock Warrant held by John Lai
Warrant expiration date September 9, 2029 Expiration of the Common Stock Warrant for 31,250 shares
restricted common stock financial
"Represents the acquisition of restricted common stock and warrants by the Reporting Person"
Restricted common stock is company shares that carry limits on selling or transferring for a set period or until certain conditions are met, like time-based vesting or regulatory clearance. Think of them as shares in a locked box that gradually open; they can become freely tradable later but initially reduce the number of shares available on the market. Investors watch restricted stock because its eventual release can change a company’s share supply, affect stock price, and influence control and dilution.
Common Stock Warrant financial
"Common Stock Warrant with an expiration date of September 9, 2029"
A common stock warrant is a tradable right that lets its holder buy a company’s common shares at a fixed price within a set time period. For investors it acts like a long‑dated option: it can magnify gains if the share price rises above the fixed price, but it also creates potential dilution because new shares are issued when warrants are used, which can reduce the value of existing shares.
private placement financial
"in connection with a private plaement investment in the Company pursuant to a subscription agreement"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
subscription agreement financial
"investment in the Company pursuant to a subscription agreement"
A subscription agreement is a legal contract in which an investor agrees to buy a specific number of a company’s shares or other securities under set terms, including price, payment method and conditions for closing the sale. It matters to investors because it legally locks in their purchase and the company’s obligations, determines ownership percentage and any investor rights, and can include conditions or promises that affect future control or returns—like signing a detailed purchase order for equity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did PETV CEO John Lai report on this Form 4/A?

John Lai reported acquiring 31,250 restricted common shares on September 9, 2026 and a warrant for 31,250 shares on September 8, 2026 as part of a private placement investment in PetVivo Holdings, Inc.

At what price did John Lai acquire PetVivo (PETV) common stock?

He acquired the 31,250 restricted common shares at a price of $0.80 per share on September 9, 2026, in connection with a private placement investment pursuant to a subscription agreement.

How many PetVivo (PETV) shares does John Lai own after these transactions?

After the reported restricted stock acquisition, John Lai directly holds 2,413,163 shares of PetVivo Holdings, Inc. common stock.

What are the key terms of the warrant acquired by John Lai in PETV?

John Lai holds a Common Stock Warrant for 31,250 shares, with an exercise price of $1.10 per share, exercisable into common stock and expiring on September 9, 2029.

Were John Lai’s PETV transactions made under a Rule 10b5-1 trading plan?

No. The filing indicates that no Rule 10b5-1 trading plan applies to these reported acquisitions of restricted common stock and the associated warrant.

How did John Lai acquire the restricted stock and warrant in PetVivo (PETV)?

The footnote states that the restricted common stock and warrants were acquired by John Lai in connection with a private placement investment in PetVivo Holdings, Inc. pursuant to a subscription agreement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lai John

(Last)(First)(Middle)
5151 EDINA INDUSTRIAL BLVD., SUITE 575

(Street)
EDINA MINNESOTA 55439

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PetVivo Holdings, Inc. [ PETV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)
09/10/2026
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/09/2026A31,250(1)A$0.82,413,163D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Common Stock Warrant$1.109/08/2026C31,25009/09/202609/09/2029Common Stock31,250$0.0031,250D
Explanation of Responses:
1. Represents the acquisition of restricted common stock and warrants by the Reporting Person in connection with a private plaement investment in the Company pursuant to a subscription agreement.
/s/ John Lai09/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading